Skip to main content
Top
Published in: BMC Public Health 1/2024

Open Access 01-12-2024 | Cervical Cancer | Research

Cervical cancer screening and its associated factors among women of reproductive age in Kenya: further analysis of Kenyan demographic and health survey 2022

Authors: Zenebe Abebe Gebreegziabher, Birhan Ewunu Semagn, Yitagesu Kifelew, Wondwosen Abey Abebaw, Werkneh Melkie Tilahun

Published in: BMC Public Health | Issue 1/2024

Login to get access

Abstract

Introduction

Although cervical cancer screening is one of the most effective strategies to reduce the incidence and mortality of cervical cancer, the percentage of cervical cancer screening in low- and middle-income counties is low. In Kenya, the current nationwide prevalence and associated factors for the detection of cervical cancer is unknown. Therefore, this study aimed to assess the prevalence and associated factors for the detection of cervical cancer screening among women of reproductive age in Kenya using the Kenyan Demographic and Health Survey 2022.

Methods

This study used the most recent Kenyan Demographic and Health Survey data (2022) with a total weighted sample of 16,901 women. A mixed effects logistic regression analysis was performed and in the multivariable analysis, variables with a p-value below 0.05 were considered statistically significant. The strength of the association was evaluated using adjusted odds ratios along with their corresponding 95% confidence intervals.

Results

The prevalence of cervical cancer screening in Kenya was 16.81%(95% CI: 16.24, 17.38%). Having a history of abortion (AOR = 1.33, 95% CI: 1.171.50, 1.43), using modern contraceptive methods (AOR = 1.57, 95% CI: 1.25, 1.95), media exposure (AOR = 1.31, 95%CI: 1.03, 1.65), primary education (AOR = 1.56, 95%CI: 1.09, 2.22), secondary education (AOR = 21.99, 95% CI: 1.1.38, 2.87), higher education (AOR = 2..50, 95% CI: 1.71, 3.65), visiting health facility within the past 12 months (AOR = 1.61, 95%CI: 1.46, 1.79), positive HIV status (AOR: 3.50, 95% CI: 2.69, 4.57), being from a community with a higher proportion of educated individuals (AOR = 1.37, 95%CI: 1.13, 1.65) and being from a community with high proportion of poor individuals (AOR = 0.72, 9 5%CI: 0.60–0.87)) were significantly associated with cervical cancer screening.

Conclusion

In Kenya, the prevalence of cervical cancer screening was found to be low. A history of abortion, use of modern contraceptives, exposure to the media, visits to health facilities in the past 12 months, HIV status, level of education, community educational level, and community wealth were identified as significant associated factors for cervical cancer screening. Therefore, it is recommended to implement targeted public health interventions that focus on these identified factors to improve the adoption of cervical cancer screening in Kenya.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bray F, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.CrossRefPubMed Bray F, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.CrossRefPubMed
2.
go back to reference Fitzmaurice C, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol. 2017;3(4):524–48.MathSciNetCrossRefPubMed Fitzmaurice C, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol. 2017;3(4):524–48.MathSciNetCrossRefPubMed
3.
go back to reference Sung H, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.CrossRefPubMed Sung H, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.CrossRefPubMed
4.
go back to reference Beddoe AM. Elimination of cervical cancer: challenges for developing countries. Ecancermedicalscience. 2019;13 Beddoe AM. Elimination of cervical cancer: challenges for developing countries. Ecancermedicalscience. 2019;13
5.
go back to reference Magalhães GM, et al. Update on human papilloma virus-part I: epidemiology, pathogenesis, and clinical spectrum. An Bras Dermatol. 2021;96:1–16.CrossRefPubMed Magalhães GM, et al. Update on human papilloma virus-part I: epidemiology, pathogenesis, and clinical spectrum. An Bras Dermatol. 2021;96:1–16.CrossRefPubMed
6.
go back to reference Khan MJ, et al. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst. 2005;97(14):1072–9.CrossRefPubMed Khan MJ, et al. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst. 2005;97(14):1072–9.CrossRefPubMed
7.
go back to reference Arbyn M, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020;8(2):e191–203.CrossRefPubMed Arbyn M, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020;8(2):e191–203.CrossRefPubMed
8.
go back to reference Organization, W.H, Human papillomavirus (HPV) and cervical cancer. Key facts 2018. Organization, W.H, Human papillomavirus (HPV) and cervical cancer. Key facts 2018.
9.
10.
go back to reference Rs MB, Prazuck T, Lethu T, Meye JF, Bélec L. Cervical cancer in sub-Saharan Africa: an emerging and preventable disease associated with oncogenic human papillomavirus. Medecine et sante tropicales. 2017;27(1):16–22.CrossRef Rs MB, Prazuck T, Lethu T, Meye JF, Bélec L. Cervical cancer in sub-Saharan Africa: an emerging and preventable disease associated with oncogenic human papillomavirus. Medecine et sante tropicales. 2017;27(1):16–22.CrossRef
11.
go back to reference Ginsburg O, et al. The global burden of women’s cancers: a grand challenge in global health. Lancet. 2017;389(10071):847–60.CrossRefPubMed Ginsburg O, et al. The global burden of women’s cancers: a grand challenge in global health. Lancet. 2017;389(10071):847–60.CrossRefPubMed
12.
go back to reference Bruni L, et al. Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis. Lancet Glob Health. 2016;4(7):e453–63.CrossRefPubMed Bruni L, et al. Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis. Lancet Glob Health. 2016;4(7):e453–63.CrossRefPubMed
13.
go back to reference Mwaka AD, et al. Symptomatic presentation with cervical cancer in Uganda: a qualitative study assessing the pathways to diagnosis in a low-income country. BMC Womens Health. 2015;15(1):1–13.CrossRef Mwaka AD, et al. Symptomatic presentation with cervical cancer in Uganda: a qualitative study assessing the pathways to diagnosis in a low-income country. BMC Womens Health. 2015;15(1):1–13.CrossRef
14.
go back to reference Momberg M, et al. Women's experiences with cervical cancer screening in a colposcopy referral clinic in Cape Town, South Africa: a qualitative analysis. BMJ Open. 2017;7(2):e013914.CrossRefPubMedPubMedCentral Momberg M, et al. Women's experiences with cervical cancer screening in a colposcopy referral clinic in Cape Town, South Africa: a qualitative analysis. BMJ Open. 2017;7(2):e013914.CrossRefPubMedPubMedCentral
15.
go back to reference Sievers D, White H. Evidence series: cervical Cancer screening and prevention, and barriers to uptake. Washington, DC: Population Services International; 2016. Sievers D, White H. Evidence series: cervical Cancer screening and prevention, and barriers to uptake. Washington, DC: Population Services International; 2016.
16.
go back to reference Parkin DM. Population risk factors for late-stage presentation of cervical cancer in sub-Saharan Africa. Cancer Epidemiol. 2018;53:81–92.CrossRef Parkin DM. Population risk factors for late-stage presentation of cervical cancer in sub-Saharan Africa. Cancer Epidemiol. 2018;53:81–92.CrossRef
17.
go back to reference Moyer VA, U.P.S.T. Force*. Screening for cervical cancer: US preventive services task force recommendation statement. Ann Intern Med. 2012;156(12):880–91.CrossRefPubMed Moyer VA, U.P.S.T. Force*. Screening for cervical cancer: US preventive services task force recommendation statement. Ann Intern Med. 2012;156(12):880–91.CrossRefPubMed
19.
go back to reference Ferlay J, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893–917.CrossRefPubMed Ferlay J, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893–917.CrossRefPubMed
20.
go back to reference Health, M.o.P., Sanitation, and M.o.M. Services, National Cervical Cancer Prevention Program: Strategic plan 2012–2015. 2012. Health, M.o.P., Sanitation, and M.o.M. Services, National Cervical Cancer Prevention Program: Strategic plan 2012–2015. 2012.
21.
go back to reference Tiruneh FN, et al. Individual-level and community-level determinants of cervical cancer screening among Kenyan women: a multilevel analysis of a Nationwide survey. BMC Womens Health. 2017;17:1–14.CrossRef Tiruneh FN, et al. Individual-level and community-level determinants of cervical cancer screening among Kenyan women: a multilevel analysis of a Nationwide survey. BMC Womens Health. 2017;17:1–14.CrossRef
22.
go back to reference Ashtarian H, et al. Knowledge about cervical cancer and pap smear and the factors influencing the pap test screening among women. International journal of community based nursing and midwifery. 2017;5(2):188.PubMed Ashtarian H, et al. Knowledge about cervical cancer and pap smear and the factors influencing the pap test screening among women. International journal of community based nursing and midwifery. 2017;5(2):188.PubMed
23.
go back to reference Ferlay J, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86.CrossRefPubMed Ferlay J, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86.CrossRefPubMed
24.
go back to reference Morris R. Factors associated with the uptake of cervical cancer screening among women of reproductive age in Homabay County, Kenya: a case of Kanyadhiang sub location. Clin in Mot and Child Heal. 2016;13(1) Morris R. Factors associated with the uptake of cervical cancer screening among women of reproductive age in Homabay County, Kenya: a case of Kanyadhiang sub location. Clin in Mot and Child Heal. 2016;13(1)
25.
go back to reference Ba DM, et al. Prevalence and determinants of cervical cancer screening in five sub-Saharan African countries: a population-based study. Cancer Epidemiol. 2021;72:101930.CrossRefPubMedPubMedCentral Ba DM, et al. Prevalence and determinants of cervical cancer screening in five sub-Saharan African countries: a population-based study. Cancer Epidemiol. 2021;72:101930.CrossRefPubMedPubMedCentral
26.
go back to reference Cunningham MS, et al. Cervical cancer screening and HPV vaccine acceptability among rural and urban women in Kilimanjaro region, Tanzania. BMJ Open. 2015;5(3):e005828.CrossRefPubMedPubMedCentral Cunningham MS, et al. Cervical cancer screening and HPV vaccine acceptability among rural and urban women in Kilimanjaro region, Tanzania. BMJ Open. 2015;5(3):e005828.CrossRefPubMedPubMedCentral
27.
go back to reference Kangmennaang J, et al. Investigating the disparities in cervical cancer screening among Namibian women. Gynecol Oncol. 2015;138(2):411–6.CrossRefPubMed Kangmennaang J, et al. Investigating the disparities in cervical cancer screening among Namibian women. Gynecol Oncol. 2015;138(2):411–6.CrossRefPubMed
28.
go back to reference Nguyen AB, Clark TT, Belgrave FZ. Gender roles and acculturation: relationships with cancer screening among Vietnamese American women. Cult Divers Ethn Minor Psychol. 2014;20(1):87.CrossRef Nguyen AB, Clark TT, Belgrave FZ. Gender roles and acculturation: relationships with cancer screening among Vietnamese American women. Cult Divers Ethn Minor Psychol. 2014;20(1):87.CrossRef
29.
go back to reference Desta M, et al. Cervical cancer screening utilization and predictors among eligible women in Ethiopia: a systematic review and meta-analysis. PLoS One. 2021;16(11):e0259339.CrossRefPubMedPubMedCentral Desta M, et al. Cervical cancer screening utilization and predictors among eligible women in Ethiopia: a systematic review and meta-analysis. PLoS One. 2021;16(11):e0259339.CrossRefPubMedPubMedCentral
30.
go back to reference Al Yahyai T, Al Raisi M, Al Kindi R. Knowledge, attitudes, and practices regarding cervical cancer screening among Omani women attending primary healthcare centers in Oman: a cross-sectional survey. Asian Pacific Journal of Cancer Prevention: APJCP. 2021;22(3):775.CrossRefPubMedPubMedCentral Al Yahyai T, Al Raisi M, Al Kindi R. Knowledge, attitudes, and practices regarding cervical cancer screening among Omani women attending primary healthcare centers in Oman: a cross-sectional survey. Asian Pacific Journal of Cancer Prevention: APJCP. 2021;22(3):775.CrossRefPubMedPubMedCentral
31.
go back to reference Gan DEH, Dahlui M. Cervical screening uptake and its predictors among rural women in Malaysia. Singapore Med J. 2013;54(3):163–8.CrossRefPubMed Gan DEH, Dahlui M. Cervical screening uptake and its predictors among rural women in Malaysia. Singapore Med J. 2013;54(3):163–8.CrossRefPubMed
32.
go back to reference Ho V, et al. Predictors of breast and cervical screening in Vietnamese women in Harris County, Houston, Texas. Cancer Nurs. 2005;28(2):119–29.CrossRefPubMed Ho V, et al. Predictors of breast and cervical screening in Vietnamese women in Harris County, Houston, Texas. Cancer Nurs. 2005;28(2):119–29.CrossRefPubMed
33.
go back to reference Niyonsenga G, et al. Knowledge, utilization and barriers of cervical cancer screening among women attending selected district hospitals in Kigali-Rwanda. Can Oncol Nurs J. 2021;31(3):266.CrossRefPubMedPubMedCentral Niyonsenga G, et al. Knowledge, utilization and barriers of cervical cancer screening among women attending selected district hospitals in Kigali-Rwanda. Can Oncol Nurs J. 2021;31(3):266.CrossRefPubMedPubMedCentral
34.
go back to reference Gakidou E, Nordhagen S, Obermeyer Z. Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities. PLoS Med. 2008;5(6):e132.CrossRefPubMedPubMedCentral Gakidou E, Nordhagen S, Obermeyer Z. Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities. PLoS Med. 2008;5(6):e132.CrossRefPubMedPubMedCentral
35.
go back to reference Thomas VN, Saleem T, Abraham R. Barriers to effective uptake of cancer screening among black and minority ethnic groups. Int J Palliat Nurs. 2005;11(11):562–71.CrossRefPubMed Thomas VN, Saleem T, Abraham R. Barriers to effective uptake of cancer screening among black and minority ethnic groups. Int J Palliat Nurs. 2005;11(11):562–71.CrossRefPubMed
36.
go back to reference Phaswana-Mafuya N, Peltzer K. Breast and cervical cancer screening prevalence and associated factors among women in the south African general population. APJCP. 2018;19(6):1465.PubMedPubMedCentral Phaswana-Mafuya N, Peltzer K. Breast and cervical cancer screening prevalence and associated factors among women in the south African general population. APJCP. 2018;19(6):1465.PubMedPubMedCentral
37.
go back to reference Compaore S, et al. Barriers to cervical cancer screening in Burkina Faso: needs for patient and professional education. J Cancer Educ. 2016;31:760–6.CrossRefPubMedPubMedCentral Compaore S, et al. Barriers to cervical cancer screening in Burkina Faso: needs for patient and professional education. J Cancer Educ. 2016;31:760–6.CrossRefPubMedPubMedCentral
38.
go back to reference Sawadogo B, et al. Knowledge and beliefs on cervical cancer and practices on cervical cancer screening among women aged 20 to 50 years in Ouagadougou, Burkina Faso, 2012: A cross-sectional study. Pan Afr Med J. 2014;18:175.CrossRefPubMedPubMedCentral Sawadogo B, et al. Knowledge and beliefs on cervical cancer and practices on cervical cancer screening among women aged 20 to 50 years in Ouagadougou, Burkina Faso, 2012: A cross-sectional study. Pan Afr Med J. 2014;18:175.CrossRefPubMedPubMedCentral
39.
go back to reference Liebermann EJ, et al. Social and cultural barriers to women’s participation in pap smear screening programs in low-and middle-income Latin American and Caribbean countries: an integrative review. J Transcult Nurs. 2018;29(6):591–602.CrossRefPubMed Liebermann EJ, et al. Social and cultural barriers to women’s participation in pap smear screening programs in low-and middle-income Latin American and Caribbean countries: an integrative review. J Transcult Nurs. 2018;29(6):591–602.CrossRefPubMed
40.
go back to reference Bao H, et al. Significant variations in the cervical cancer screening rate in China by individual-level and geographical measures of socioeconomic status: a multilevel model analysis of a nationally representative survey dataset. Cancer Med. 2018;7(5):2089–100.CrossRefPubMedPubMedCentral Bao H, et al. Significant variations in the cervical cancer screening rate in China by individual-level and geographical measures of socioeconomic status: a multilevel model analysis of a nationally representative survey dataset. Cancer Med. 2018;7(5):2089–100.CrossRefPubMedPubMedCentral
41.
go back to reference Damiani G, et al. The impact of level of education on adherence to breast and cervical cancer screening: evidence from a systematic review and meta-analysis. Prev Med. 2015;81:281–9.CrossRefPubMed Damiani G, et al. The impact of level of education on adherence to breast and cervical cancer screening: evidence from a systematic review and meta-analysis. Prev Med. 2015;81:281–9.CrossRefPubMed
42.
go back to reference Soneji S, Fukui N. Socioeconomic determinants of cervical cancer screening in Latin America. Rev Panam Salud Publica. 2013;33(3):174–82.CrossRefPubMed Soneji S, Fukui N. Socioeconomic determinants of cervical cancer screening in Latin America. Rev Panam Salud Publica. 2013;33(3):174–82.CrossRefPubMed
44.
go back to reference Reyes-Ortiz CA, et al. Health insurance and cervical cancer screening among older women in Latin American and Caribbean cities. Int J Epidemiol. 2008;37(4):870–8.CrossRefPubMedPubMedCentral Reyes-Ortiz CA, et al. Health insurance and cervical cancer screening among older women in Latin American and Caribbean cities. Int J Epidemiol. 2008;37(4):870–8.CrossRefPubMedPubMedCentral
Metadata
Title
Cervical cancer screening and its associated factors among women of reproductive age in Kenya: further analysis of Kenyan demographic and health survey 2022
Authors
Zenebe Abebe Gebreegziabher
Birhan Ewunu Semagn
Yitagesu Kifelew
Wondwosen Abey Abebaw
Werkneh Melkie Tilahun
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2024
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-024-18148-y

Other articles of this Issue 1/2024

BMC Public Health 1/2024 Go to the issue